AI assistant
ETHZilla Corp — Director's Dealing 2025
Apr 12, 2025
33039_dirs_2025-04-11_46aa4ce4-29e5-4b12-8644-cafe42a8db39.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2025-03-27
Reporting Person: ELRAY RESOURCES, INC. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-27 | Common Stock | C | 1318000 | — | Acquired | 1318000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-27 | Series B Convertible Preferred Stock | $ | C | 1000000 | Disposed | Common Stock (1318000) | Direct |
Footnotes
F1: On March 27, 2025, Elray Resources, Inc., converted all 1,000,000 outstanding shares of Series B Convertible Preferred Stock of the Issuer which it then held into 1,318,000 shares of common stock (1.318 shares of common stock for each share of Series B Convertible Preferred Stock converted), in accordance with the terms of such preferred stock and the optional conversion right set forth therein.
F2: Each of the 1,000,000 shares of Series B Convertible Preferred Stock was convertible into 1.318 shares of common stock.
F3: The Series B Convertible Preferred Stock has no expiration date.